Please sign in to follow a disease.
New clot test could speed up care for postpartum bleeding
NCT ID NCT05127642
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a device called Sonoclot to quickly measure blood clotting in 90 women who had severe bleeding within 24 hours after giving birth. The goal was to see if this point-of-care test could help doctors spot clotting problems faster and improve treatment. The study is complete, but it was only observational, so it does not prove that using Sonoclot leads to better outcomes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors quickly identify clotting problems in women with severe bleeding after childbirth, potentially guiding better treatment.
- What could go wrong
- This is a small, completed observational study, not a treatment trial. The findings may not change current practice without larger, more definitive research.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
90 people
The number who actually took part.
- Started
-
Dec 2024
- Finished
-
Dec 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study will be conducted in Assiut University Hospital, both clinical pathology department and obstetric and gynaecological department.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. patients in childbearing period. 2. Patients with bleeding occurring in the first 24 hours after delivery (primary postpartum hemorrhage). 3. Patients with causes of Postpartum hemorrhage like uterine atony, preeclampsia, blood diseases as inherited and prepartum acquired coagulopathies, and others e.g., acute fatty liver of pregnancy, amniotic fluid embolism, etc. Exclusion Criteria: 1. Patients with bleeding after 24 hours from delivery (secondary postpartum hemorrhage). 2. Patients with miscarriages (bleeding before 22 weeks of gestation) or Antepartum hemorrhage. 3. Traumatic causes of postpartum hemorrhage e.g., rupture uterus, abruptio placenta, Lacerations, hematomas, Uterine inversion, and iatrogenic trauma.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Postpartum hemorrhage are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assiut university
Asyut, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a slower oxytocin infusion prevent dangerous blood pressure drops in C-Sections?
- A 12-minute video could save new mothers' lives – can it teach them to spot danger?
- Can a simple calcium tablet help prevent postpartum bleeding?
- Medical glue vs. internal bleeding: a new hope?
- Which drug stops Post-Birth bleeding better? a Head-to-Head test
- Could a simple calcium injection prevent dangerous bleeding after childbirth?